10th ESO SIOPE Masterclass in Paediatric Oncology

COURSE LEADERSHIP

Chairs: A. Attarbaschi, AT - A. Ferrari, IT - C. Rizzari, IT - B. Timmermann, DE
Host Chairs: G. Chantada, ES - J. Mora, ES
Online Chairs: K. Scheinemann, CH

AIMS, OBJECTIVES AND TEACHING FORMAT

The ESO Masterclass is a full immersion, clinical oriented event designed for paediatric oncologists with 3–4 years of experience in oncology who would like to receive further training on the treatment of children tumours from a multidisciplinary point of view.

The programme exposes participants to a full spectrum of issues in paediatric oncology and to practice-oriented training.
The Masterclass is organized into:

• Plenary lectures on state-of-the-art clinical treatments with reference to clinical guidelines given by renowned international faculty.
• Interactive workshop on communication
• Clinical case presentations/tumour board simulation where each participant presents and discusses a case with an international faculty of top experts in each tumour type.

The Masterclass is divided into two educational parts:

1. Pre-recorded online lectures
2. In-person event

The online lectures are released before the in-person event to give each participant the opportunity to prepare themselves in their own time and at their own place.

The in-person event is held in the style of a 2-and-half-day ‘retreat’, giving participants the opportunity to begin building an international oncology network as well as the chance to interact with renowned faculty in an informal environment over a number of days.

The Masterclass is held entirely in English and fluency in English is necessary for admission.

MAIN TOPICS

• Bone tumours
  • Central nervous system tumours
  • Leukemia
  • Lymphoma
  • Neuroblastoma
  • Rare tumours
  • Soft-tissue sarcoma
  • Wilms’ tumour

LANGUAGE

The Masterclass will be held in English and translation will not be provided.

FEE

The Masterclass will take place at Hospital Sant Joan de Deu, Barcelona, Spain.

A fee of 250,00 euros covers:

• Access to the course and its educational resources
• Accommodation for 3 nights at Abba Garden Hotel, Barcelona
• Meals according to the programme

The fee does not cover travel costs: these should be organized and paid by the participant.

Participants who are ESO College members at the time of application will receive a 50% discount.

The registration fee for this event is a small contribution towards the cost for organising it, therefore it will not be refunded if a participant withdraws or is unable to attend, for whatever reason.

Should you have any queries, please do not hesitate to contact the event organisers:
Sonia Bulgarelli – sbulgarelli@eso.net

Elena Fiore – efiore@eso.net

ACCREDITATION

Participants will be issued a certificate of attendance (minimum attendance: 75% of the online part + 100% of the in-person event). An online evaluation questionnaire and learning assessment test will need to be completed for both parts in order to get the certificate that will be sent by email.
Application for accreditation will be made to the Accreditation Council of Oncology in Europe (ACOE).

ESO COLLEGE MEMBERSHIP

Being selected to take part in this course is one of the ESO activities that gives participants eligibility to enrol in ESO’s College. The course also enables members of the College to earn credits and therefore access more membership benefits. Full and active participation in the course earns participants 30 ESO College credits.

Visit www.ESCO.org for more information on how to join the College.

ORGANISING SECRETARIAT

Sonia Bulgarelli
European School of Oncology
ph +39 337 1061207
e-mail: sbulgarelli@eso.net

Elena Fiore
European School of Oncology
ph + 39 335 169 4160
e-mail: efiore@eso.net

APPLICATIONS DEADLINE 4 DECEMBER 2026

ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY.

50 PARTICIPANTS WILL BE SELECTED.

IDEAL PROFILE OF THE MASTERCLASS CANDIDATE

• Aged up to 40 years
• 2-3 years’ experience in peadiatric oncology
• Involvement in scientific activities and clinical trials
• Fluency in English
• From ESO’s geographical reach: Europe, Mediterranean countries and Latin America 

HOW TO APPLY

Interested oncologists should apply online (at the top of this page).

The application process involves completing an online questionnaire, where you will provide details about:

• Your work experience and training
• Your research experience and publications
• Your motivation and personal commitment to participating in this activity

During the application, you will also need to upload the following documents in PDF format:

• Recommendation letter: A letter from your head of department or mentor, written on official hospital letterhead and signed.
• Curriculum Vitae (CV)
• Clinical case: Please use the provided template available below.

SELECTION PROCESS

Applications are evaluated through a two-step process:

1. Automated Scoring: Some responses are assessed using a predefined scoring system to ensure fairness and consistency. Points are assigned based on your answers.
2. Committee Evaluation: Other sections, including your qualitative responses, are reviewed and scored by our selection committee.

This type of evaluation ensures a transparent and unbiased selection of top candidates for participation in this activity.

Before you start completing the online application form, please be sure you have all the requested files (CV, Recommendation letter, and Clinical Case template) ready to be uploaded to the system. Online applications will not be considered unless all the files are uploaded.

TEMPLATE

Download your Clinical case template HERE 

CLINICAL CASE PRESENTATION

During the in-person event all participants will have the chance to present a clinical case as a clinical grandround discussion to the faculty and participants. A template giving details of the clinical case you would like to present should be submitted with your application. Please provide a straightforward case found in your daily clinical practice - no uncommon or extremely rare cases. You should include

• Diagnostic considerations
• Treatment
• Results, follow-up
• At least three questions proposed for discussion with the faculty

If you are selected for the Masterclass, you will be asked to prepare a PowerPoint presentation of your case (max 10 slides). If we receive too many cases from one tumour group, we may ask you to change the case topic you submitted during your application. We kindly ask you to let us know your 2^nd choice topic if your first choice cannot be accommodated.

Andishe Attarbaschi, Saint Anna Children's Hospital, Dept. of Paediatrics, Vienna, AT
Jette Bakhuizen, Universitair Medisch Centrum Utrecht, ., Utrecht, NL
André Baruchel, University Hospital Robert Debré (APHP), Pediatric Hematology-Immunology Dept., Paris, FR
Luisa Basset-salom, ES
Paco Bautista, Prinsess Maxima Centre, ., Utrecht, AT
Gianni Bisogno, University of Padova, Dept. of Women's and Children's Health, Padova, IT
Alicia Castañeda Heredia, Hospital Sant Joan de Deu, ., Barcelona, ES
Giovanni Cazzaniga, Ospedale San Gerardo, Centro Ricerca Tettamanti, Monza, IT
Guillermo Chantada, Hospital Garrahan, Dept.of Haemato-Oncology, Buenos Aires, AR
Emilia Comas, Hospital Sant Joan de Deu, ., Barcelona, ES
Karin Dieckmann, AKH Wien, Dept. of Radiotherapy, Vienna, AT
Uta Dirksen, University Hospital Essen, Dept. of Pediatrics III, Hematology/Oncology, Essen, DE
François Doz, Institut Curie, Paediatric Oncology Dpt., Paris, FR
Angelika Eggert, Charité University Medicine Berlin, Dept. of Paediatric Oncology/ Haematology, Berlin, DE
Andrea Ferrari, Fondazione IRCCS Istituto Nazionale dei Tumori, Div. di Oncologia Pediatrica, Milano, IT
Maite Gorostegui, Sant Joan de Deu Barcelona, ., Esplugues de Llobegrat, ES
Norbert Graf, Saarland University Hospital (UKS), Dept. for Pediatric Oncology and Hematology, Homberg, DE
Jacques Grill, Institut Gustave Roussy, Dept. of Paediatric and Adolescent Oncology, Villejuif, FR
Hannah Gsell, AT
Oskar Haas, Children's Cancer Research Institute, ., Wien, AT
Henrik Hasle, Aarhus University Hospital, Dept. of Pediatrics, Aarhus N, DK
Jan Inge Henter, Karolinska Institute, ., Stockholm, SE
Shushan Hovsepyan, Yeolyan Hematology and Oncology Center, Dept. of Pediatric Oncology/Hematology, Yerevan, AM
Geert Janssens, University Medical Center Utrecht, ., Utrecht, NL
Leo Kager, St Anna Children's Hospital, Dept. of Hematology, Oncology & Immunology, Vienna, AT
Ana Lacerda, IPO Lisboa, Lisbon, PT
Alvaro Lassaletta, University Children's Hospital Nino Jesus, Paediatric Hematology Oncology Dpt., Madrid, ES
Alvaro Lassaletta, University Children's Hospital Nino Jesus, Paediatric Hematology Oncology Dpt., Madrid, ES
Cinzia Lavarino, Hospital Sant Joan de Deu, Barcelona, ES
Thomas Lehrnbecher, University Children's Hospital, Dept. of Pediatric Hematology/Oncology, Frankfurt am Main, DE
Maura Massimino, National Cancer Institute - IRCCS Foundation, Pediatric Oncology Dept., Milano, IT
Christine Mauz-Körholz, Universitätsklinikum Giessen und Marburg, Dept. of Pediatric Hemotology and Oncology, Giessen, DE
Jaume Mora, Hospital Sant Joan de Deu, ., Barcelona, ES
Andres Morales, Hospital Sant Joan de Deu, ., Barcelona, ES
Bruce Morland, Birmingham Children's Hospital, Oncology Dpt., Birmingham, UK
Daniel Orbach, Curie Institute, Paediatrics, Adolescent, Young Adults SIREDO Center, Paris, FR
Bob Phillips, University of York, ., York, UK
Susana Rives, Hospital Sant Joan de Deu, ., Barcelona, ES
Carmelo Rizzari, Fondazione IRCCS San Gerardo, University of Milano-Bicocca, Pediatric Hematology-Oncology Dpt., Monza, IT
Hector Salvador, Hospital Sant Joan de Deu, ., Barcelona, ES
Katrin Scheinemann, Stiftung Ostschweizer Kinderspital, Paediatric Oncology Dpt., St. Gallen, CH
Dominik Schneider, Klinik für Kinder- und Jugendmedizin, Klinikum Dortmund, Dortmund, DE
Martin Schrappe, University Medical Center Schleswig-Holstein, Campus Kiel, Dept. of General Pediatrics, Kiel, DE
Thorsten Simon, University Clinic Köln, Dept. of Pediatric Oncology and Hematology, Köln, DE
Filippo Spreafico, Fondazione Irccs Istituto Nazionale Dei Tumori, Dept. Of Medical Oncology And Hematology, Milano, IT
Beate Timmermann, UK-Essen, WPE, Essen, DE
Jaime Verdú Amorós, GVA.ES - Generalitat Valenciana, ., Valencia, ES